Ultromics partners with Pfizer to advance EchoGo AI technology
Ultromics’ EchoGo Amyloidosis algorithm has been designed for early detection of cardiac amyloidosis.
11 January 2024
11 January 2024
Ultromics’ EchoGo Amyloidosis algorithm has been designed for early detection of cardiac amyloidosis.
Veracyte will first apply C2i’s minimal residual disease tests to bladder cancer, with further indications to follow.
The deal expands GE Healthcare’s diagnostic imaging portfolio.
Neurolief’s Relivion is the first neuromodulation device for at-home use in the acute treatment of migraine approved in Japan.
Supported by a £300,000 donation, the trial is set to enrol hospital patients across the UK in hopes of using spinal cord stimulation to restore quality of life.
NVIDIA announced new advances to the healthcare industry at the J P Morgan Healthcare Conference, including its partnership with Amgen.
The non-invasive tool is launched in the US with the Clarius PAL HD3, Clarius PA HD3, and Clarius C3 HD3 models.
The OptiView transparent dressing with HydroCore Technology is designed for skin monitoring and pressure injury prevention.
GlobalData predicts that the major technology themes expected to influence the medical device industry in 2024 are AI, cybersecurity, robotics, AI regulation, and digitalization. Furthermore, remote patient monitoring and precision medicine have been identified as the major industry themes set to shape the the medical devices market in 2024.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Give your business an edge with our leading industry insights.